General Notices

• Notice of a Pre-Application Webinar for RFA-CA-20-032, Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)
  (NOT-CA-20-023)
  National Cancer Institute
  

• Salary Limitation on AHRQ FY2020 Grants, Cooperative Agreements, and Contracts
  (NOT-HS-20-006)
  Agency for Healthcare Research and Quality
  

• Notice of Data Sharing Policy for Autism Data
  (NOT-MH-20-010)
  National Institute of Mental Health
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  

• Findings of Research Misconduct
  (NOT-OD-20-056)
  National Institutes of Health
  

• Notice of Information: National Death Index Linkage Access for NIH-Supported Investigators
  (NOT-OD-20-057)
  Office of Behavioral and Social Sciences Research
  

• Request for Information (RFI) Seeking Stakeholder Input on Scientific Gaps and Research Needs to Address Associations Between Environmental Exposures and Cancer Risk
  (NOT-CA-20-024)
  National Cancer Institute
  

• Request for Information (RFI) on Improved Understanding of Risk and Mechanisms for Developing Obesity in Infants and Young Children
  (NOT-DK-20-004)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Heart, Lung, and Blood Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  

Notice of Changes to Funding Opportunities

• Notice Of Correction in Application Due Date information for NOT-AA-19-031 "Notice of Special Interest on Neurobehavioral Mechanisms of Social Isolation and Alcohol Use Disorder (AUD) "
  (NOT-AA-20-001)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice to expire NOT-AR-20-012, "HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Notice of Special Interest (NOSI) regarding the Availability of Competitive Revisions."
  (NOT-AR-20-015)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Correction to NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) PAR-20-069
  (NOT-DE-20-007)
  National Institute of Dental and Craniofacial Research
  

• Notice to Extend the Expiration Date for PAR-18-215 "Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
  (NOT-HD-20-001)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice to Extend the Expiration Date for PAR-18-214 "Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
  (NOT-HD-20-002)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NHLBI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
  (NOT-HL-19-742)
  National Heart, Lung, and Blood Institute
  

• Notice of NHLBI Participation in PAR-19-342 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
  (NOT-HL-19-743)
  National Heart, Lung, and Blood Institute
  

• Notice of Correction to Open Date in RFA-NS-19-043 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
  (NOT-NS-20-037)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for NIAMS Rheumatic Diseases Research Resource-based Centers (P30)
  (NOT-AR-20-013)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional) and to Hold a Pre-Application Technical Assistance Webinar.
  (NOT-MD-20-012)
  National Institute on Minority Health and Health Disparities
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional)
  (NOT-NR-20-002)
  National Institute of Nursing Research
  National Institute on Drug Abuse
  National Institute of Mental Health
  

Requests for Proposal

• 2020 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2020-1 Now Available
  (NOT-AI-20-025)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions.
  (NOT-AR-20-016)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  

• Notice of Special Interest: Administrative Supplements to Support Collaborations with the NCI-supported PDX Development and Trial Centers Research Network (PDXNet)
  (NOT-CA-20-020)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers
  (NOT-CA-20-022)
  National Cancer Institute
  

• Notice of Special Interest: Alzheimers-focused administrative supplements for NIH/NIDDK grants that are not focused on Alzheimers disease
  (NOT-DK-20-009)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Special Interest: Availability of Administrative Supplements to INBRE Awards to Fund Research Collaborations
  (NOT-GM-20-012)
  National Institute of General Medical Sciences
  

• Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
  (NOT-HD-19-035)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
  (NOT-HG-20-010)
  National Human Genome Research Institute
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
  (NOT-OD-20-055)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  

Funding Opportunities

• NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
  (PAR-20-080)
  National Institute of Mental Health
  Application Receipt Date(s): May 26, 2020; May 25, 2021; May 25, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)
  (PAR-20-081)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): April 1, 2020, April 1, 2021, and April 1, 2022
  
  

• Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
  (PAR-20-086)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): March 17, 2020
  
  

• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed)
  (PAR-20-088)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): April 1, 2020, April 1, 2021, and April 1, 2022 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Biomedical Data Repository (U24 - Clinical Trials Not Allowed)
  (PAR-20-089)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023
  
  

• NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed
  (PAR-20-090)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): March 2, 2020; July 1, 2020; November 2, 2020; March 1, 2021; July 1, 2021;November 1, 2021; March 1, 2022; July 1, 2022; November 1, 2022;
  
  

• Revision Applications - FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)
  (PAR-20-091)
  Food and Drug Administration
  Application Receipt Date(s): March 25, 2020, by 11:59 PM Eastern Time. March 25, 2021, by 11:59 PM Eastern Time. March 25, 2022, by 11;59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
  (PAR-20-093)
  National Institute of Mental Health
  Application Receipt Date(s): May 24, 2022
  
  

• NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed)
  (PAR-20-094)
  National Institute of Mental Health
  Application Receipt Date(s): May 26, 2020; May 25, 2021, May 25, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed)
  (PAR-20-095)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is May 25, 2020.
  
  

• NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
  (PAR-20-096)
  National Institute of Mental Health
  Application Receipt Date(s): May 26, 2020; May 25, 2021; May 25, 2022
  
  

• Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)
  (PAR-20-097)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023
  
  

• Medications Development for the Treatment of Alcohol Use Disorder (AUD) or Alcohol-Related Organ Damage (AROD), or the Combination of AUD and AROD (U01 Clinical Trial Optional)
  (RFA-AA-20-007)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): March 26, 2020
  
  

• New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed)
  (RFA-AG-21-003)
  National Institute on Aging
  Application Receipt Date(s): October 7, 2020
  
  

• Limited Competition: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed)
  (RFA-AG-21-005)
  National Institute on Aging
  Application Receipt Date(s): June 17, 2020.
  
  

• Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional)
  (RFA-AG-21-011)
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): October 2, 2020
  
  

• Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (U19 Clinical Trial Not Allowed)
  (RFA-AI-20-001)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 08, 2020
  
  

• Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)
  (RFA-CA-20-004)
  National Cancer Institute
  Application Receipt Date(s): April 30, 2020; November 17, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
  (RFA-CA-20-005)
  National Cancer Institute
  Application Receipt Date(s): April 30 , 2020; November 17, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
  (RFA-DK-19-032)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 14, 2020; September 2, 2020; March 2, 2021. All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Drug Development Tools Research Grants (U01 Clinical Trial Optional)
  (RFA-FD-20-009)
  Food and Drug Administration
  Application Receipt Date(s): March 17, 2020
  
  

• Novel Approaches to Advance Coordinated Registry Networks (CRNs) (U01 Clinical Trial Optional)
  (RFA-FD-20-021)
  Food and Drug Administration
  Application Receipt Date(s): March 13, 2020
  
  

• Renewal - Integrated Food Safety System Online Research and Collaboration Development (U18) Clinical Trials Not Allowed
  (RFA-FD-20-023)
  Food and Drug Administration
  Application Receipt Date(s): March 25, 2020
  
  

• Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)
  (RFA-HD-20-003)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): April 03, 2020
  
  

• Mendelian Genomics Research Centers (U01 Clinical Trial Optional)
  (RFA-HG-20-007)
  National Human Genome Research Institute
  Application Receipt Date(s): April 15, 2020
  
  

• Mendelian Genomics Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-HG-20-008)
  National Human Genome Research Institute
  Application Receipt Date(s): April 15, 2020
  
  

• Accelerating Medicine Partnership in Parkinsons disease (AMP PD) data use and analysis (U01 Clinical trials not allowed)
  (RFA-NS-20-027)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): March 18, 2020.
  
  

• Limited Competition: Microphysiological Systems Database Center (MPS DC) (U24 Clinical Trials Not Allowed)
  (RFA-TR-20-002)
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): March 13, 2020